Physician profile
Aaron E Katz
NPI 1740399922
$19,242.46
in general payments reported to CMS, 2019-2025
19 companies · $799 in 2025
The $799 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $21.80 · 2021: $14.93 · 2022: $803 · 2023: $15K · 2024: $2,527 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $3,213 · Travel and Lodging: $1,425 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,500.00 |
| Food and Beverage | $3,213.36 |
| Travel and Lodging | $1,424.94 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15,848.52 | 2022-2025 | Spaceoar System, Spaceoar Vue System - 10ml |
| Procept Biorobotics Corporation | $1,217.14 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Palette Life Sciences, INC. | $719.06 | 2022-2023 | |
| Teleflex LLC | $244.50 | 2022-2023 | Urolift |
| Coloplast Corp | $211.45 | 2023-2024 | Isiris Astent Removal Device |
| Pfizer INC. | $143.28 | 2024 | |
| Astellas Pharma US INC | $141.16 | 2019-2024 | |
| Axonics, INC. | $126.97 | 2023 | Bulkamid |
| Progenics Pharmaceuticals, INC. | $122.32 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $103.20 | 2024 | |
| Biogen, INC. | $89.77 | 2022 | |
| Janssen Biotech, INC. | $87.37 | 2019 | |
| Antares Pharma, INC. | $61.58 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Ferring Pharmaceuticals INC. | $35.83 | 2019 | |
| Shionogi INC | $28.98 | 2024 | Fetroja |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $24.60 | 2025 | |
| Cumberland Pharmaceuticals, INC. | $21.80 | 2020 | |
| Allergan, INC. | $14.93 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.